Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)

Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)

Bibliographic Details
Main Authors:	Palermo F, Mughini M T, Gussio M, Mavilla S, La Rosa R, Celesia B M, Bisicchia F, Russo R
Format:	Article
Language:	English
Published:	BMC 2010-05-01
Series:	BMC Geriatrics

Similar Items

Tolerability of antiretroviral therapy (HAART) in elderly age
by: Celesia B M
Published: (2010-05-01)

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
by: Christian Akem Dimala, et al.
Published: (2016-01-01)

A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
by: Christian Akem Dimala, et al.
Published: (2016-01-01)

Functional changes of the vasculature in HIV/AIDS patients on Haart and Haart Naïve HIV participants
by: Awotedu, Kofoworola Olajire
Published: (2013)

Immunological and virological responses in highly active antiretroviral therapy naive patients exposed to isoniazid preventive therapy
by: Manda, Robert
Published: (2010)

Immunological and virological responses in highly active antiretroviral therapy naive patients exposed to isoniazid preventive therapy
by: Manda, Robert
Published: (2010)

Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART
by: Daniel Mark, et al.
Published: (2006-05-01)

The influence of HCV coinfection on clinical, immunological and virological responses to HAART in HIV-patients
by: Ricardo A. Carmo, et al.

Virological failure and HIV-1 drug resistance mutations among naive and antiretroviral pre-treated patients entering the ESTHER program of Calmette Hospital in Cambodia.
by: Hubert Barennes, et al.
Published: (2014-01-01)

Emergence of primary NNRTI resistance mutations without antiretroviral selective pressure in a HAART-treated child.
by: Elizabeth S Machado, et al.
Published: (2009-01-01)

Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.
by: Lealem Gedefaw, et al.
Published: (2013-01-01)

Factors that influence adherence to highly active antiretroviral therapy (HAART).
by: Naicker, Michaela Helene.
Published: (2013)

Pregnancy and virologic response to antiretroviral therapy in South Africa.
by: Daniel Westreich, et al.
Published: (2011-01-01)

A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes.
by: Michael H Chung, et al.
Published: (2011-03-01)

Monitoring the virological response to antiretroviral therapy in Africa
by: John, Laurence Michael
Published: (2007)

Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.
by: Annelot F Schoffelen, et al.
Published: (2013-01-01)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
by: Sinha Rajesh, et al.
Published: (2008-01-01)

Impaired CCR7 Expression on Plasmacytoid Dendritic Cells in HIV Infected Children on HAART With Virologic Failure
by: Pahwa Rajendra, et al.
Published: (2005-12-01)

Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study
by: Ganesan Anuradha, et al.
Published: (2011-05-01)

Virological, Molecular And Immuno-Biochemical Studies Of Lumpy Skin Disease In Naturally Infected Cattle
by: Morcos Ibrahim Yanni, et al.
Published: (2021-01-01)

Cardiac Effects of Antiretroviral-Naïve versus Antiretroviral-Exposed HIV Infection in Children.
by: Nikmah S Idris, et al.
Published: (2016-01-01)

Kinetics and Determining Factors of the Virologic Response to Antiretrovirals during Pregnancy
by: Adriana Weinberg, et al.
Published: (2009-01-01)

Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia.
by: Genet Gebrehiwet Hailu, et al.
Published: (2018-01-01)

Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients
by: Hamilton Domingos, et al.

Behavioral Characteristics of Adult Patients on Highly Active Antiretroviral Therapy (HAART) in Uganda
by: Constance Shumba, et al.
Published: (2012-01-01)

Behavioral Characteristics of Adult Patients on Highly Active Antiretroviral Therapy (HAART) in Uganda
by: Constance Shumba
Published: (2012-01-01)

The impact of in-utero highly active antiretroviral therapy (HAART) exposure on infant outcomes
by: Van der Merwe, Karin Joan
Published: (2011)

Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug naïve in Limbe, Cameroon
by: Agyingi L, et al.
Published: (2012-09-01)

Blood Cell Membrane Fluidity and Intracellular Ca2+ Changes in Antiretroviral-Naïve and -Treated HIV-1–Infected Patients
by: Nuno C. Santos, et al.
Published: (2010-01-01)

Predictors of Virologic Failure in HIV/AIDS Patients Treated with Highly Active Antiretroviral Therapy in Brasilia, Brazil during 2002–2008
by: Edson José Monteiro Bello M.Sc., et al.
Published: (2011-01-01)

Virological and immunological stabilisation in AIDS-presenter, regardless antiretroviral therapy
by: Roberto Manfredi
Published: (2010-06-01)

Prevalence of antiretroviral drug resistance among treatment-naive and treated HIV-infected patients in Venezuela
by: Héctor Rafael Rangel, et al.
Published: (2009-05-01)

Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.
by: Pontiano Kaleebu, et al.
Published: (2015-01-01)

Evaluating a minipool strategy to screen for virologic failure and antiretroviral drug resistance
by: H.M. Newman, et al.
Published: (2014-04-01)

Programmatic and Individual-level Factors Associated with CD4 Cell Count at HAART Initiation and Survival Among Treatment-naïve Patients Initiating HAART in sub-Saharan Africa.
by: Eduardo, Eduard
Published: (2014)

Maraviroc in Antiretroviral-Naïve HIV-1 Patients
by: Beniam Ghebremedhin
Published: (2012-01-01)

Maraviroc in Antiretroviral-Naïve HIV-1 Patients
by: Beniam Ghebremedhin
Published: (2012-01-01)

Studying the Causes of Virologic Failure in the Early Stages of Antiretroviral Therapy in HIV-Infected Patients
by: M.H. Liulchuk
Published: (2015-02-01)

Lipodystrophy in Human Immunodeficiency Virus (HIV) Patients on Highly Active Antiretroviral Therapy (Haart)
by: N. Sunil Kumar, et al.
Published: (2015-07-01)

Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
by: Dereudre-Bosquet Nathalie, et al.
Published: (2009-09-01)